Literature DB >> 33372407

Risk factors of the severity of COVID-19: A meta-analysis.

Abdur Rahman1, Nusrat Jahan Sathi1.   

Abstract

OBJECTIVE: We intend to identify some probable risk factors that are responsible for the severity of COVID-19 using a meta-analysis.
METHODS: The literature exploration lasted up to 18 April 2020 and through PubMed, Google Scholar, EMBASE and Cochrane Library we have identified 10 pertinent publications. To paraphrase the outcomes of autonomous researches, we have performed a random-effect meta-analysis.
RESULTS: A total of 2272 patients' information was extracted from the selected literature. We have found gender (male) (Risk ratio [RR] = 1.29, 95% Confidence Interval [CI] 1.07 to 1.54), hypertension (RR = 1.79, 95% CI 1.57 to 2.04), diabetes (RR = 1.57, 95% CI 1.25 to 1.98), fatigue or myalgia (RR = 1.17, 95% CI 1.02 to 1.35), and smoking history (RR = 1.71, 95% CI 1.25 to 2.35) are potential risk factors for the severity of COVID-19. We found fever (RR = 1.21, 95% CI 0.66 to 2.22), cough (1.13, 95% CI 0.98 to 1.30) and diarrhoea (RR = 1.14, 95% CI 0.93 to 1.40) as insignificant risk factors for COVID-19 severity.
CONCLUSIONS: The findings of this research may be beneficial to identify patients with higher risks to provide additional medical attention from the very beginning of the treatment.
© 2020 John Wiley & Sons Ltd.

Entities:  

Year:  2020        PMID: 33372407     DOI: 10.1111/ijcp.13916

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  12 in total

Review 1.  Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence.

Authors:  Marina Treskova-Schwarzbach; Laura Haas; Sarah Reda; Antonia Pilic; Anna Borodova; Kasra Karimi; Judith Koch; Teresa Nygren; Stefan Scholz; Viktoria Schönfeld; Sabine Vygen-Bonnet; Ole Wichmann; Thomas Harder
Journal:  BMC Med       Date:  2021-08-27       Impact factor: 8.775

2.  Neurological symptoms and complications in predominantly hospitalized COVID-19 patients: Results of the European multinational Lean European Open Survey on SARS-Infected Patients (LEOSS).

Authors:  Nina N Kleineberg; Samuel Knauss; Eileen Gülke; Hans O Pinnschmidt; Carolin E M Jakob; Paul Lingor; Kerstin Hellwig; Achim Berthele; Günter Höglinger; Gereon R Fink; Matthias Endres; Christian Gerloff; Christine Klein; Melanie Stecher; Annika Y Classen; Siegbert Rieg; Stefan Borgmann; Frank Hanses; Maria M Rüthrich; Martin Hower; Lukas Tometten; Martina Haselberger; Christiane Piepel; Uta Merle; Sebastian Dolff; Christian Degenhardt; Björn-Erik O Jensen; Maria J G T Vehreschild; Johanna Erber; Christiana Franke; Clemens Warnke
Journal:  Eur J Neurol       Date:  2021-09-03       Impact factor: 6.288

3.  Are Individuals with Substance Use Disorders at Higher Risk of SARS-CoV-2 Infection? Population-Based Registry Study in Northern Italy.

Authors:  Olivera Djuric; Pamela Mancuso; Angela Zannini; Antonio Nicolaci; Marco Massari; Alessandro Zerbini; Lucia Belloni; Giorgia Collini; Fabio Sampaolesi; Anna Celotti; Iulica Boni; Paolo Giorgi Rossi
Journal:  Eur Addict Res       Date:  2021-05-05       Impact factor: 3.015

4.  Uncovering Clinical Risk Factors and Predicting Severe COVID-19 Cases Using UK Biobank Data: Machine Learning Approach.

Authors:  Kenneth Chi-Yin Wong; Yong Xiang; Liangying Yin; Hon-Cheong So
Journal:  JMIR Public Health Surveill       Date:  2021-09-30

5.  COVID-19 infection and hospitalization rate in Iranian multiple sclerosis patients: What we know by May 2021.

Authors:  Saba Naghavi; Aryan Kavosh; Iman Adibi; Vahid Shaygannejad; Sina Arabi; Maryam Rahimi; Shahbanoo Mazaheri; Fereshteh Ashtari
Journal:  Mult Scler Relat Disord       Date:  2021-10-16       Impact factor: 4.339

6.  Nitric oxide-mediated cutaneous microvascular function is not altered in young adults following mild-to-moderate SARS CoV-2 infection.

Authors:  Gabrielle A Dillon; S Tony Wolf; Lacy M Alexander
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-01-07       Impact factor: 4.733

7.  Multimorbidity Profiles and Infection Severity in COVID-19 Population Using Network Analysis in the Andalusian Health Population Database.

Authors:  Jonás Carmona-Pírez; Ignatios Ioakeim-Skoufa; Antonio Gimeno-Miguel; Beatriz Poblador-Plou; Francisca González-Rubio; Dolores Muñoyerro-Muñiz; Juliana Rodríguez-Herrera; Juan Antonio Goicoechea-Salazar; Alexandra Prados-Torres; Román Villegas-Portero
Journal:  Int J Environ Res Public Health       Date:  2022-03-23       Impact factor: 3.390

8.  Social belonging, compassion, and kindness: Key ingredients for fostering resilience, recovery, and growth from the COVID-19 pandemic.

Authors:  George M Slavich; Lydia G Roos; Jamil Zaki
Journal:  Anxiety Stress Coping       Date:  2021-08-09

9.  Time to hospitalisation, CT pulmonary involvement and in-hospital death in COVID-19 patients in an Emergency Medicine Unit.

Authors:  Luca Marino; Marianna Suppa; Antonello Rosa; Adriana Servello; Alessandro Coppola; Mariangela Palladino; Anna Maria Mazzocchitti; Emanuela Bresciani; Luigi Petramala; Giuliano Bertazzoni; Daniele Pastori
Journal:  Int J Clin Pract       Date:  2021-06-16       Impact factor: 3.149

10.  Multiple Secondary Healthcare-Associated Infections Due to Carbapenem-Resistant Organisms in a Critically Ill COVID-19 Patient on Extensively Prolonged Venovenous Extracorporeal Membrane Oxygenation Support-A Case Report.

Authors:  Hiroaki Baba; Hajime Kanamori; Issei Seike; Ikumi Niitsuma-Sugaya; Kentaro Takei; Kengo Oshima; Yudai Iwasaki; Yuko Ogata; Hirona Nishimaki; Daisuke Konno; Takuya Shiga; Koji Saito; Koichi Tokuda; Tetsuji Aoyagi
Journal:  Microorganisms       Date:  2021-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.